GlassScriptPhysician profile
Haidy M Behman
NPI 1568447241
$8,020.33
in general payments reported to CMS, 2019-2025
53 companies · $1,004 in 2025
The $1,004 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,039 · 2020: $769 · 2021: $1,349 · 2022: $1,043 · 2023: $1,441 · 2024: $1,376 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,794 · Education: $26.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,794.19 |
| Education | $26.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,478.69 | 2019-2025 | Mounjaro, Kisunla, Jardiance |
| Abbvie INC. | $1,433.28 | 2021-2025 | Qulipta, Ubrelvy |
| Corcept Therapeutics | $459.80 | 2020-2025 | Korlym |
| Dexcom, INC. | $362.63 | 2021-2024 | Dexcom G6 Transmitter |
| Biohaven Pharmaceuticals, INC. | $330.59 | 2021 | |
| Abbott Laboratories | $303.15 | 2021-2025 | Freestyle Libre |
| Novo Nordisk INC | $268.43 | 2019-2024 | Ozempic, Rybelsus |
| Lundbeck LLC | $245.43 | 2022-2024 | Vyepti |
| Kyowa Kirin, INC. | $236.86 | 2019-2023 | Crysvita |
| Eisai INC. | $205.73 | 2021-2023 | |
| Pfizer INC. | $202.58 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $201.26 | 2019-2021 | |
| Ucb, INC. | $192.96 | 2019-2025 | Briviact, Nayzilam |
| Teva Pharmaceuticals USA, INC. | $182.08 | 2019-2025 | Austedo Xr |
| Neurocrine Biosciences, INC. | $152.42 | 2024-2025 | Ingrezza |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haidy Behman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.